drugset
drugset / Trial / NCT03591861

Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis

NCT03591861 ↗

Terminated 2 enrolled Washington University School of Medicine
NaSingle-groupOpen-labelTreatment

Summary

The investigators will develop the concept of a sex-specific therapeutic intervention for gliomas that is based upon dietary carbohydrate restriction. The investigators will integrate metabolomics tools and FDG-PET imaging to validate the ketogenic diet on a sex-specific basis.

Timeline

Start
2019-05-01
Primary completion
2022-11-01
Completion
2022-11-01

Drugs

EvaluationDrugModalityDoseRoute
Background carmustine Small molecule — —

Indications

brain cancer